Company Filing History:
Years Active: 2014
Title: Janet Gunzner-Tate: Pioneering Innovations in Pharmaceutical Development
Introduction
Janet Gunzner-Tate, a notable inventor based in Piedmont, California, is recognized for her significant contributions to the field of pharmaceuticals. With a focus on innovative compounds, she has made strides in developing solutions aimed at addressing critical health issues.
Latest Patents
Janet holds a patent for "Aminopyrimidine derivatives as LRRK2 modulators," which includes compounds of formula I and pharmaceutically acceptable salts thereof. This patent reflects her dedication to exploring new therapeutic avenues, particularly in the modulation of LRRK2, a target related to various neurodegenerative diseases.
Career Highlights
Throughout her career, Janet has been associated with Genentech, Inc., a leading biotechnology company known for its cutting-edge research and development in pharmaceuticals. Her expertise in medicinal chemistry and innovative thinking has positioned her as a valuable asset to her team and the greater scientific community.
Collaborations
In her professional journey, Janet has collaborated with esteemed colleagues, including Charles Baker-Glenn and Daniel J. Burdick. These partnerships underscore the importance of teamwork in driving innovations and enhancing research output in the pharmaceutical domain.
Conclusion
Janet Gunzner-Tate's work exemplifies the impact of innovative thinking and collaboration in the invention of novel pharmaceutical solutions. Her patent and contributions to Genentech, Inc. highlight her role as an influential figure in the field of drug development, paving the way for future advancements that may improve patient outcomes.